Calendar ImmunityBio, Inc.

Equities

IBRX

US45256X1037

Market Closed - Nasdaq 04:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
5.49 USD +11.13% Intraday chart for ImmunityBio, Inc. +11.59% +9.36%

Chart calendar ImmunityBio, Inc.

4533f341c4fb5c252942e532d680.G3vWhCHQ0IKGKUpHT_PB0-ckkIuVMqoPHEkKXXV8vWI.eBGwwU6TqsjXYxAlN4KNsddVyvzhQN59UQZpawIy6wxBFoDCTYez6OpgAw~0bcaabe6860080a4c1398ff9750934e3

Upcoming events on ImmunityBio, Inc.

2024-04-26 11:00 am ANKTIVA® FDA Approval Call
2024-05-02 American Urological Association Meeting
2024-05-30 American Society of Clinical Oncology Annual Meeting

Past events on ImmunityBio, Inc.

2023-11-30 10:30 am Piper Sandler Healthcare Conference
2023-11-03 Society for Immunotherapy of Cancer Meeting - Abstract Number :358
2023-11-01 LUGPA Meeting
2023-10-31 Society for Immunotherapy of Cancer Meeting
2023-07-06 AACR - AHNS Joint Conference
2023-06-13 12:30 pm Annual General Meeting
2023-06-13 12:30 pm Annual General Meeting
2023-06-07 10:00 am Jefferies Global Healthcare Conference
2023-06-01 ASCO Meeting
2023-04-27 American Urological Association Meeting - Booth no. 3807
2023-03-27 Hanson Wade Innate Killer Summit
2023-02-16 02:30 pm American Society of Clinical Oncology Genitourinary Cancers Symposium - Abstract No: 495
2023-01-18 American Society of Clinical Oncology Gastrointestinal Cancers Symposium
2022-11-29 02:30 pm Piper Sandler Healthcare Conference - Fireside Chat
2022-11-15 11:25 am Jefferies London Healthcare Conference
2022-08-07 Interim 2022 Earnings Release
2022-06-14 12:30 pm Annual General Meeting
2022-06-02 American Society of Clinical Oncology Meeting - QUILT 88 Poster Session
2022-06-02 American Society of Clinical Oncology Meeting - QUILT 3.032 Oral Presentation
2022-03-15 04:00 am J.P. Morgan South Africa Healthcare Conference

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,93
0,57
64.15%
0,24
0,30
-18.92%
0,62
0,51
22.44%

9,68

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-330
-331
0.21%
-351
-335
-4.74%
-362
-357
-1.52%

-364

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-350
-341
-2.51%
-417
-398
-4.82%
-584
-474
-23.26%

-459

Net income
Million USD
Released
Forecast
Spread
-347
-341
-1.62%
-417
-398
-4.64%
-583
-474
-23.11%

-459

EPS
USD
Released
Forecast
Spread
-0,89
-1,35
34.07%
-1,04
-0,94
-10.64%
-1,15
-0,93
-23.66%

-0,68

Announcement Date01/03/2201/03/2319/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,39
0,03
1460%
0,01
0,03
-44%
0,04


0,12
0,06
88.8%
0,07
0,03
192%
0,36
0,03
1340%
0,04
0,03
64%
0,08
0,40
-79.5%
0,14
0,03
456%

0,03


0,53


2,53


6,61


10,0

EBIT
Million USD
Released
Forecast
Spread
-79,3
-80,0
0.88%
-96,0
-80,0
-20%



-90,8
-75,0
-21.11%
-84,9
-75,0
-13.24%
-112
-95,0
-17.48%
-85,1
-100,0
14.83%
-80,1
-73,0
-9.78%
-85,4
-80,0
-6.77%

-85,0


-89,6


-87,9


-101


-76,7

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-91,6
-83,0
-10.33%
-103
-85,7
-20.25%



-111
-86,3
-28.79%
-108
-89,1
-21.55%
-117
-109
-6.5%
-138
-116
-19.62%
-95,6
-80,5
-18.81%
-233
-123
-89.39%

-108


-113


-112


-126


-76,6

Net income
Million USD
Released
Forecast
Spread
-91,3
-83,0
-9.97%
-103
-85,7
-20.05%



-111
-86,3
-28.53%
-108
-89,1
-21.46%
-116
-109
-6.28%
-138
-116
-19.33%
-95,6
-79,7
-20%
-233
-123
-89.34%

-108


-113


-112


-126


-72,8

EPS
USD
Released
Forecast
Spread
-0,23
-0,21
-9.52%
-0,26
-0,22
-18.18%
-0,24
-0,24
0%
-0,28
-0,22
-30.23%
-0,27
-0,17
-63.64%
-0,27
-0,27
0%
-0,32
-0,24
-36.17%
-0,19
-0,18
-5.56%
-0,38
-0,18
-111.11%

-0,16


-0,17


-0,17


-0,19


-0,11

Announcement Date01/03/2210/05/2208/08/2209/11/2201/03/2311/05/2308/08/2309/11/2319/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IBRX Stock
  4. Calendar ImmunityBio, Inc.